{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:08:18Z","timestamp":1792541298449,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T00:00:00Z","timestamp":1354752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10792-012-9688-0","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T22:54:59Z","timestamp":1354748099000},"page":"557-560","source":"Crossref","is-referenced-by-count":16,"title":["Brimonidine\u2013timolol fixed combination induced granulomatous inflammation of the eye"],"prefix":"10.1007","volume":"33","author":[{"given":"Mar\u00eda Alejandra","family":"Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo Ariel","family":"Schlaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Oscar","family":"Z\u00e1rate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,6]]},"reference":[{"key":"9688_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0149-2918(00)87981-3","volume":"22","author":"S Melamed","year":"2000","unstructured":"Melamed S, David R (2000) Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results. Brimonidine Study Group II. Clin Ther 22:103\u2013111","journal-title":"Clin Ther"},{"key":"9688_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00061198-200204000-00007","volume":"11","author":"LJ Katz","year":"2002","unstructured":"Katz LJ (2002) Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension. J Glaucoma 11:119\u2013126","journal-title":"J Glaucoma"},{"key":"9688_CR3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/archopht.124.9.1230","volume":"124","author":"MB Sherwood","year":"2006","unstructured":"Sherwood MB, Craven ER, Chou C et al (2006) Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial. Arch Ophthalmol 124:1230\u20131238","journal-title":"Arch Ophthalmol"},{"key":"9688_CR4","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1185\/03007990802333167","volume":"24","author":"MA Motolko","year":"2008","unstructured":"Motolko MA (2008) Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy. Curr Med Res Opin 24:2663\u20132667","journal-title":"Curr Med Res Opin"},{"key":"9688_CR5","first-page":"137","volume":"80","author":"PJ Cano","year":"2005","unstructured":"Cano PJ, Diaz-Llopis M (2005) Drug induced uveitis. Arch Soc Esp Oftalmol 80:137\u2013149","journal-title":"Arch Soc Esp Oftalmol"},{"key":"9688_CR6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archopht.122.7.1063","volume":"122","author":"HI Becker","year":"2004","unstructured":"Becker HI, Walton RC, Diamant JI, Zegans ME (2004) Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate. Arch Ophthalmol 122:1063\u20131066","journal-title":"Arch Ophthalmol"},{"key":"9688_CR7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0002-9394(00)00491-8","volume":"130","author":"DB Byles","year":"2000","unstructured":"Byles DB, Frith P, Salmon JF (2000) Anterior uveitis as a side effect of topical brimonidine. Am J Ophthalmol 130:287\u2013291","journal-title":"Am J Ophthalmol"},{"key":"9688_CR8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archopht.125.5.717-a","volume":"125","author":"JA Alvarado","year":"2007","unstructured":"Alvarado JA (2007) Reduced ocular allergy with fixed-combination 0.2% brimonidine-0.5% timolol. Arch Ophthalmol 125:717\u2013718","journal-title":"Arch Ophthalmol"},{"key":"9688_CR9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0090-9556(25)06647-4","volume":"23","author":"AA Acheampong","year":"1995","unstructured":"Acheampong AA, Shackleton M, Tang-Liu DD (1995) Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits. Drug Metab Dispos 23:708\u2013712","journal-title":"Drug Metab Dispos"},{"key":"9688_CR10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/IJG.0b013e3181132188","volume":"17","author":"EV Nguyen","year":"2008","unstructured":"Nguyen EV, Azar D, Papalkar D, McCluskey P (2008) Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features. J Glaucoma 17:40\u201342","journal-title":"J Glaucoma"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-012-9688-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-012-9688-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-012-9688-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T10:13:15Z","timestamp":1745403195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-012-9688-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,6]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9688"],"URL":"https:\/\/doi.org\/10.1007\/s10792-012-9688-0","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,6]]}}}